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Letters to the Edi tor
RESEARCII ON NTFANTS
Srn,-Dr Pratt (March 26, p. 699) asks for "guidclines
about the orcunrstances in which it ir legally pcrmissible and
ahically acceptable to rakc blood f'rom miaors (particularly
babics) purcly for purporca ofrescarch". This important qucs-
tion was the subiect of an editorial in Archiws of Disease in
Childhoo4t which Dr Pratt may 6ad gocs iorn€ way to provid-
ing what shc sceks. Thc following points werc thcrc madc.
(1.) Thc Mdical Rcscarch Council's statement of 1963 irr
plying that such blood-sampling would be illcgal cannot be
acceptcd as giving an incontrovertible opiuion on how thc law
now standsl a contrery iatcrpretation was rcached by Curran
and Beechcr,z lbr instance. The mattcr remains open, having
n€ver trccn tested in thc courtr,
(2.) A value iudgnent ia involved, Is the potential gain in
medical knowledge comrncnsuratc with possible discomforr or
pain to the'6aby? Thc rame principle should be applied
whether the invotigation involvcs rrivial ioterfercncc with the
baby-e.g., weighing it morc often than ugual--or less trivial,
as with blood-sampling.
(3.) Such value iudgmcnt is !e*t made by a local ethical
reseArch commrttgc.
Dr Pratt's local ethical cornmitrce nrmber who told hcr that
the committee would regard blood*ampling fiom children for
rcse$rch as not lcgally pcrmisriblc, was presumably mcrely cit-
ing the M.R.C.'s queltiooeble opinion. Shc nccd not havc l€ft
the rnattcr thcrc: shc rhould bave put hcr originel rcscarch
proposals to thc cthicrl committcc, accompanied by copics of
the editorial rcfcrred ro or thq,pdmirable article by Campbclls
on the same subjcct.
l7 Ruthertbrd Road;
Canbridge CB2 2HH Doucles Gllnpxtn
Srn -Dr Pratt has raiod thc quostion of blood-sampling in
infants whcrc thc inveetigariou rcenoc ro bc of no dircct bcnefrt
to thc babie* Lite many othm, rhc har found it difficulr ro
perruCdc her local cthical rts€Brcb committe. that thc in-
formed conscnt ofparents is'sufficicnt to allow hcr to carry out
ouch rcsearch investigationo otr rnfmt*
It is tirnc that romc clcar lcad was given to pediatric invcsti-
gators in thi$ impoflsnt mrttcr. Thc law, ae intcrpretcd by the
Modical Reaearch Cbuncil, sccnrs to bc that such proccdurcr
are illegal, Whilc it is clear that romc rafcgrnrdr arc nccdcd,
it is logically indcfcnsiblc to adopr thc position that normal ir
dividuals (of whatever age) arc nat prop€r subicctr for inveeti
gation. If this wcre the ca*c thcn it would bc utcthical to inv6-
dgarc thc rick pcrson becau* wc would hcyc no etsnd{rds to
which to relate our data, which would rhug be madc mcaning-
lcss. The qu€stioo, {ren, is rhe dcgrec to which intcrference
with the healthy pcrson is permisrible. In thc view of the
M.R.C. and thc Medical Ddencc Union thir apparcntly stops
shon of venepuncture and fingerprick.
"Why thesc proccdurcs chwld bc utrcthical, whcrcgg
lneacuremcnt ofheighr, wcight, hcad circumfcrcncg ard com-
ponentl of uring bcing lesr invasivc, arc prcrumably pcrmit-
ted, is not imnqdiately apparlent. Onc could argue rhat thcy in-
volvc greater risk and greatcr pain to the snbfcct. Thcre arc
indeed risks of both venepundunc and capillary blood+am-
pling-hamatomaa may bc produrxd uirich may bccome in-
fcctcd; excessivc hemomhagc loay occur; artcriovenous ancu-
rysms, air embolL aad oneomyelitis hart becn dcscribcd.
Scrious complicauons of thir kiad are vcry ranr. Thc fra that
L Archs Dit. Chil.lh. L971,18,751.
2. Curran, \v. J., Bchcr, H. K.t- Am. mcd. Ass. 1969,210,77
3. Crmpbelt, A. G. M. Br. mcd. J. 197+, \r,314.
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they may be scqueke of a proccdurr wbich war not lanctly
necesary for thc wcllbcing of a particular child docs not mrfe
that proccdure unethical so long as thc untowerd conplicadon
rernains a rcmotc poaribility. Orherwigc ir would bc irnmorel to
take a young child on a motorcar iourncy whicb was not spcci-
tically fbr hir bendit: the risks ofhis bcing involved in a road-
traffic accident would be too grcat,
The sccond rcagon for banning ruch invdritsdons on
childrcn might be on thc grounds of the pail iavolved. W9 sub-
mit that if thc parcnts would givc co$cnl for rcdlc puncturc
upon themsclvcs, as part d a rgearch invcrtigation, thcn it is
pcrfcctly reasonable for thcm to givc such cofficnt on bchalf
oftheh child, Vc havc no rcason to supporc thrr infrnrs arc
lcss altruirdc than thcir parentr. From thcir point of view,,thcy
are, for admireblc rcasons, subiccrcd to tbc pgin of, vrccinr
don, but thcy havc no monc 'rndcrstanding of tbe wonhy
motivc behind this paiuful proedurc than ofthc equally wcll
motivstcd obicctivcr of mdicd rc*arch. It ir our qpcricrcc
that childrrn, by thc timc thcy arc l0 y*an ofagg rrc oot oaly
able to undcrrtand but nre alro usualy vcry willing to partici-
pbte in ruch rcacarcb proccdurer. lt ir paradodcal thst I ro
cicty which allows parenu considcrable ipdividucl &ccdpn to
ncgicct or ill-trtat thcir childrcn, dcob thooc ramc parents tbc
right ro inyolve their children in rrcdical rercarch dcoigncd to
allevilrc hunrn ruffering.
Dcprtmnt d Child Hcihh,
Wclrh Nrtional Schml ot Mcdtine,
CardiflC!-4 4XN
Jorx A Doocr
foux Evans
IIEPA$N.IIKB INHIBITO& NOT TITA.TNII-X
DEFTCIENCI,IN THB I{EWBOIN .
$tr,-Viramin-K dcfcicacy rn maa crurcr norpal pro.
rhrambin to decrcgrc, and abnormal prothrombil to appcar in
thc blood.t Wc chcckcd for viramin-K d.ficicocy in thc ncw-
born by tciring for abnormal prothroebin. In 43 hcalthy
babies a 20 cm piccc of umbilical cord war dempd dircctly
after birth. 9 ml of blood was withdrsqrn by puo.crurc from thc
unrbilical vcil into a polypropylcoe syringc with I nrl of r rclu-
tion containing hydroryetbylpipcrazinc*rhenesul huric acid
(hepcs) 0.3 moVl, trisodium citrate 0.1 mol[ sodium aztile 15
mmoVl snd flpmdritr ('Trasylol') 15 mmo[4" at pH 7'3. This
ririxture prcvcntr 6brin(geno)lysir. Plasma war obtaincd by
ccntrifugatioo and madc platclet poor by a rond ccaffiuga-
tion for 30 min at 4tl and 20 000 S. It war frozco iu I ml
volumes and rtored st -20qC, In tbcsc plarmo *r c$imated2
the clotting factors pruthrombin ard fsctm v, vn, rnd x by
a onettage prncdurc and prothrmbin dso by . twffimgc
proccdure.'
Abnormal prothrombin (or protein iaducod by vitamin-K
absencc analogous to frctor n [p.t.v.r.A.-nl ) is a prccunor of
normal prothrcmbin thrt in a vitamin-Kdcpcndenr procccs
has rcn glutamic (Glu) rcsidue* convertcd into ICOOH gluta.
mic acid (Gla) reiducs.r-3 Thc Gla rcsiducs are ess.ntial for
thc normal gcncrstion of thlombin from prothroorbia by thc
physiological activator Brothrombinar,t P.l.v.K.rt.-tt docr con-
tain normal thrombin and will gcn€rotc thrwbin actieity nor-
mally with non-phyriological sctivttors ruch rr *aphylocoagu-
lase and Ectri carinatus venom.r{ p.LV.KrA.-tt obows aonplete
immunological idcntity with prothrombin and is catiearad
with prothrornbin in onedimcnsionrl cracsad irtrmumclcctrs-
l. ltcmkcr, H. C., Vclrkamp, J. J,, flcn*n, 4., Lstigrr, E. A. Nolre, 1965,
200,589.
2. tsar, B. M., Mullcr, A. D., van ds V@rt-Bcclcu, J. M. I. mol. Mcn. $75,
l , 6 5 .
3. Slcngo, J., Firnlund, P., Egan, w., Rocprtorff, P, Ptu, tetr-.Actd. Sci.
u.sa. t974,7t,2?to.
4. Nelrcrtucn, G. L., Zytkovie, T. H., Howard, I. B. l+toyo Cliz. Proc. l?74,
{9 ,941.
J. Esmon, Ch. T.r Suuic, J. W., Jaclon,C. M.l. biol. Ctn 1976,250, 4095.
6. Hemkcr, H. C., tsro, B. M., Mulls' A. l). Eiochin. bioPhlt. Acta, 1975,
,?9, lEo.
+].1.;i.;,i.iii:-trlji:,l':*.1;::
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phoresis (c.r.n.). The tablc shows that the amount of factor tl
found in those tests where p.l.v.x..t.-lr will bc cocatimatcd i3
equal ro the &mount found in the onF$tagc tcat" Hencc no
p.t.v.K.A.:g is demonstratcd in this way'
p,I.v.K.A.-rt will show up in a twdimcnsional c.t'E' whcn
calcium ions (2 mmoll calcium lactate) arc prcsent in thc firrt-
dimension run.'fhis is because Gla rcsidues bind calcium ions
and slow the electropbor€tic mobility of p-rothrombin rclativg
to that of the Glu-containinge.l .v,K.A.- l t .  Nor' t 'v 'r 'n '- t t '  could
be demonstrated in the newborn in this way cithcr'
The plasma of thc ncwborrr' thcrcforcr docs not contain'
p.t.v.x.,t.-tt and we concludc rhat hcalthy babics' contrary to
current bcliet's' are not likely to have vitamin-K deficiency'
During thesc investigations we found, in 25 9u1 -of the 43
plasmas,-a hitherto uniecognised hcparin-likc inhibitor't The
role of this inhibitor in beafth and discasc atill ha3 to be cluci*
dated. Anyway, the coagulation status of the newborn resem-
bles that of parcnteral anticoagulation (heparin) more clorely
than that oforal coaguladon (dicoumarol). Administration of
vitamin K to the newbQrn is not supponed by our findings. For
generaliscd bleeding complications in thc ncwborn proramin
chloride should be considercd.
9 l 0 l l 1 2 1 3
Age (Yearsl
Btrect of orgl cernltiac oo growth-rrtc of r boy rlft crt'nttlac
myop.thy.
in three divided doscs, was incrcascd to 4 g' Throughout thc
ilme tnt boy has becn recciving D,L<amitinc' hie n1ry\
riii"g,rt mt'trcadily improved rid h" it no longer troubled
with irausea and vomiting. I(c havc bccn furthcr imprccscd'
oanicularlv aftcr rhe latcst incrcasc in the dotc of orl<arni-
iine, by thi much improved gro*h-ratc (rcc figurc)''- 
Ouie*pd.occ, therefore, confirms rhc valuc.of orel carni-
tinc in the trestment of an othcnrisc revcrcly incapacitating
progressive discase. 
G. p. Hosrlxs
N. P. C. CavexecN
Dcpartmeil of NclroloSy' D. P.. L. Sfrfyfff
Hospiral for Sich Childrcn,
London wclN 3JH J'Wrr'soN
PIIENYI.IUIININE ITYDROXYL.IISE IN IIUMAN
PI-IICBNTA: NOVBL SYSTBM FOn STLDY OF
PIIENYTJ(BTONURIA
Sln,*Hoffbaucr and SchrempF havc dcscribed thc- activity
of phinylalanine hydrorylarc in culturcd human skin fibrc
Ulasts. \ic would liic to report thc picscnce ofa high levcl of
activity of phcnylalanine hydroxylase -in human tcrm 
placent a'
f'restr t"i- pi"".ttt"t were obtaincd within minutes of deliv-
erv. f'hin sticei t-3 mm in sizc and of l-2 g wet wcighl werc
or"eoared from each placcnta. 
'I'lrc placental fmgurents wcrc'*""ih"d 
,hto times wlth cold 0'15 mo|/l eodium chloridc solu-
tion and then incubated with I ml of tissuc culture mcdium
199 without scrum to which 550 000 counts/min (1490 pmol)
of purified r--ra()phenylalaninc was addcd. Thc fragmcnts
were incubarcd at 37qC fbr 4 h' and culturc was tcrminatcd
bv the addition of hydrochloric acid to s final cuc€nuation of
6 moVl. 
'Ihe entire icaction mixturc was hydrolysed for 20 b
ar 100t. After this hydrolysis the hydrochloric acid was cva-
porated and ramplcb of cach reaclion werc chronatographcd
a Ir0
.:J
z r?5
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120
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l)epartment of Obstcrica aod Gynecology,
lJnze Lieve Vrouwen Gasthuis,
Amstcrdan, Netherland3
Dcpanment of Bichemstry,
tsiomidical Ccntrc,
Starc Univcrsity Limbut8'
Maagtricht, Netherlands
ORAI. TNBATMANT OF CARNrTINE iIYOPATIIY
Srn -Inborn erron of carnitine mctabolism havc bccn euc-
ccssfully treatd with oral supplements of orr<arnitine.r..'Wc
have tried thb treatment in a boy with carnitinc myoplthy;
the clinical atrd biochemical findings werc describcd in 1975.r
Before diagnosis, the paticnt had bccn glven vitamin-B com-
plcx without benefit. A low-fay'high<arbohydretc dict was
tried, medium<hain triglyccrides having proved too nauseal-
ing, With this there was somc improvcmcnt and,dccrcsse in
naisca, but the patient remaincd vcry weak. With thc intro
duction of 1.5 g/day of o,l<arnitinc his musclc powcr and
performance improved. At firet higher doses of carnitinc exa-
cerbated his vomiting, but after four mqnths he was able to
rolerate 2.5 g/day and after scventcen montbi the daily intakc'
7. Mullcr, A- D., van l)mrm, J. M., l{crur*1' H. C' Ndttc (in thc prcss)'
1. Hngcl, A. G., Atrgclitt, c., Nelsn' R, A. n Erpl,oratory Conccpts in Musu-
iar Dystrophy Il (cditcd by A. T. Milhorat); P- 601' Ametcrdem' 1974'
2. Karpaii, G., Carpenrcr, S., Engel' A. G., Watrcrs, G., Allcn, J-, Rorhman'
S., Klar*n, G., Mammcr, O. A' Neutolop, Miineapolis, L975' 25. 16.
L Ansefini, C. ibid.1916,26'631.
4. Anichni, C., Luclc, S., Csnatqruni, F. t6td.
5, Smvrh, D. l'. L., likc, B. D., MscDcmot' J., Vilrcn' J. Lancet, 19"15' it
i  rse.
DE'IERMINATION OF CLOTTTNG FACTORS IN CORD BLOOD
l. tldit'auer, R. W., SchrcmPl; G . Lncet' 1976, i' 194
